Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS)

16.30 -0.18 (-1.09%) At close: 03:00PM CST

Shandong Buchang Pharmaceuticals Co., Ltd.

No. 369 Zhonghua West Road
Heze 274000
China
86 40 0678 9828
https://www.buchang.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 8,311

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Chao Zhao	President & Director	N/A	N/A	1967
Mr. Yi Min Wang	Executive VP & Vice Chairman	N/A	N/A	1961
Mr. Bao Cai Wang	Chief Financial Officer	N/A	N/A	1963
Mr. Wei Jun Li	Vice President of Administration & Personnel	N/A	N/A	1963
Mr. Ren Hui Xue	VP of Marketing & Director	N/A	N/A	1968
Mr. Xifang Wang	Chief Engineer	N/A	N/A	1960
Mr. Xiao Ping Pu	VP of Securities, Board Secretary & Director	N/A	N/A	1958
Dr. Zhao Buchang M.D.	Founder	N/A	N/A	N/A
Haiqin Wu	Chairman of the Academic Committee	N/A	N/A	N/A
Ms. Wei Zhao	Vice President of Procument	N/A	N/A	N/A

Amounts are as of 31 December 2017, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. The company offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. Shandong Buchang Pharmaceuticals Co., Ltd. was founded in 1993 and is based in Heze, China.

Corporate governance

Shandong Buchang Pharmaceuticals Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.